These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3781705)

  • 1. Diltiazem in the treatment of the irritable bowel syndrome.
    Pérez-Mateo M; Sillero C; Cuesta A; Vazquez N; Berbegal J
    Int J Clin Pharmacol Res; 1986; 6(5):425-7. PubMed ID: 3781705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome.
    Centonze V; Imbimbo BP; Campanozzi F; Attolini E; Daniotti S; Albano O
    Am J Gastroenterol; 1988 Nov; 83(11):1262-6. PubMed ID: 3055943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacologic drugs in the treatment of the irritable bowel syndrome. A double blind study of the effect of trimipramine.
    Myren J; Lövland B; Larssen SE; Larsen S
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):117-23. PubMed ID: 6529168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of irritable colon. Efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon].
    Schäfer E; Ewe K
    Fortschr Med; 1990 Aug; 108(25):488-92. PubMed ID: 2210587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a buzepide metiodide-haloperidol combination in treating functional intestinal disorders. Randomized double-blind controlled versus placebo study].
    Barbier JP; Dorf G; Gordin J; Krainik F; Neveu D; Parlier H; Richard P; Vitaux J; Fraitag B
    Ann Gastroenterol Hepatol (Paris); 1989 May; 25(3):123-8. PubMed ID: 2672998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prifinium bromide in the treatment of the irritable colon syndrome.
    Piai G; Mazzacca G
    Gastroenterology; 1979 Sep; 77(3):500-2. PubMed ID: 37142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
    Chapman ND; Grillage MG; Mazumder R; Atkinson SN
    Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.
    Cappello G; Spezzaferro M; Grossi L; Manzoli L; Marzio L
    Dig Liver Dis; 2007 Jun; 39(6):530-6. PubMed ID: 17420159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome.
    Ferrari A; Cavallero M; Spandre M; Gemme C; Rossini FP; Imbimbo BP
    Clin Ther; 1986; 8(3):320-8. PubMed ID: 3521859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome.
    Tudor GJ
    Br J Clin Pract; 1986 Jul; 40(7):276-8. PubMed ID: 3527247
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo].
    Lech Y; Olesen KM; Hey H; Rask-Pedersen E; Vilien M; Ostergaard O
    Ugeskr Laeger; 1988 Oct; 150(40):2388-9. PubMed ID: 3061106
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of two different formulations of mebeverine hydrochloride in irritable bowel syndrome.
    Gilbody JS; Fletcher CP; Hughes IW; Kidman SP
    Int J Clin Pract; 2000 Sep; 54(7):461-4. PubMed ID: 11070572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of the combination of trimetazidine (Vastarel 20 mg) with diltiazem (Tildiem 60 mg) in stable effort angina. A double-blind versus placebo multicenter study].
    Lévy S
    Ann Cardiol Angeiol (Paris); 1995 Apr; 44(4):203-12. PubMed ID: 7632029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium chloride before i.v. diltiazem in the management of atrial fibrillation.
    Kolkebeck T; Abbrescia K; Pfaff J; Glynn T; Ward JA
    J Emerg Med; 2004 May; 26(4):395-400. PubMed ID: 15093843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects.
    Morganroth J; Rüegg PC; Dunger-Baldauf C; Appel-Dingemanse S; Bliesath H; Lefkowitz M
    Am J Gastroenterol; 2002 Sep; 97(9):2321-7. PubMed ID: 12358251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome.
    Delvaux M; Beck A; Jacob J; Bouzamondo H; Weber FT; Frexinos J
    Aliment Pharmacol Ther; 2004 Jul; 20(2):237-46. PubMed ID: 15233705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of stable exercise angina with calcium blockers-a double-blind, placebo-controlled comparison of diltiazem and nifedipine].
    Klein W; Brandt D; Fluch N; Maurer E
    Z Kardiol; 1982 Jun; 71(6):398-405. PubMed ID: 6812301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of irritable colon with lidamidine and support psychotherapy].
    Rodríguez Magallán A; Valadéz Velázquez T; Llorens Torres F; Sánchez Torres MI
    Rev Gastroenterol Mex; 1997; 62(1):7-13. PubMed ID: 9190662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
    Kim HJ; Vazquez Roque MI; Camilleri M; Stephens D; Burton DD; Baxter K; Thomforde G; Zinsmeister AR
    Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.